US › Healthcare

Daxor Corporation (DXR)

US · Healthcare · Medical Instruments & Supplies

$10.52-3.04%

Last close · 2026-08-04

Latest quarter · ended 2025-12-31

Revenue

$131,846

Revenue YoY

+267.5%

Net profit

$9.5M

Profit YoY

+1269.9%

EPS

$-0.07

EPS estimate

$0.00

Net margin

7,235.3%

Key statistics

Market cap

$61.3M

P/E

6.4

Forward P/E

64.5

P/B

1.34

Book value

$9.07

EPS (TTM)

$1.64

52-week high

$14.76

52-week low

$8.56

50-day MA

$10.33

200-day MA

$11.61

Beta

0.26

Analyst view

Analysts rate Daxor Corporation a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $22.50.

Shareholding

Insiders

49.45%

Institutions

6.56%

Largest institutional holders

Fund	Stake
Thompson, Siegel & Walmsley LLC	3.98%
Vanguard Capital Management, LLC	0.83%
Aristides Capital LLC	0.71%
Renaissance Technologies Corp	0.48%
Susquehanna International Group, LLP	0.23%
NANO CAP NEW MILLENNIUM GROWTH FUND L P	0.21%
Crescent Grove Advisors, LLC	0.18%
SBI Securities Co Ltd	0.05%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Daxor Corporation — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.